Application of PROTAC In The New Field of Attenuated Vaccines
Researchers developed a live attenuated influenza A virus vaccine using proteolysis targeting chimera (PROTAC) technology to degrade viral proteins through the endogenous ubiquitin-proteasome system of host cells.
Like this book? You can publish your book online for free in a few
minutes!